- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Joel Wayment Discusses the Logistical Challenges of CAR T-Cell Distribution and Storage
The logistics for storing chimeric antigen receptor (CAR) T-cell therapies remain a challenge, said Joel Wayment, vice president of operations for 3PL Services, Cardinal Health.
The logistics for storing chimeric antigen receptor (CAR) T-cell therapies remains a challenge, said Joel Wayment, vice president of operations for 3PL Services, Cardinal Health.
Transcript
Have the logistics of cold storage for CAR T-cell therapies improved as more have been approved and due to the needs of COVID-19 vaccines?
You know, the logistics for storing CAR T therapies has improved some, but it has a ways to go. There's a lot to evolve. Today, sites of administration really don't have the necessary capabilities to store multiple CAR T therapies for long durations of time. And so, there's work to be done there and how we help solve some of the challenges of storage of these types of products that require these unique temperatures.
How are partnerships needed to ensure the personalized supply chain for each CAR T-cell therapy goes smoothly and successfully?
You know, to continue to ensure a smooth flow of operations between product and patient, you have to have some strong partnerships. There needs to be collaboration and communication between the patient logistics and really coordinating the patient being ready for the administration, as well as the product. And so, those partners have to be talking and communicating to ensure a successful outcome.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
